CA1092028A - Composes pharmaceutiques utilises comme bronchodilatateur - Google Patents

Composes pharmaceutiques utilises comme bronchodilatateur

Info

Publication number
CA1092028A
CA1092028A CA284,372A CA284372A CA1092028A CA 1092028 A CA1092028 A CA 1092028A CA 284372 A CA284372 A CA 284372A CA 1092028 A CA1092028 A CA 1092028A
Authority
CA
Canada
Prior art keywords
pirbuterol
hydroxyzine
dihydrochloride
composition
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA284,372A
Other languages
English (en)
Inventor
Norman E. Pitts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of CA1092028A publication Critical patent/CA1092028A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
CA284,372A 1976-08-26 1977-08-09 Composes pharmaceutiques utilises comme bronchodilatateur Expired CA1092028A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71790576A 1976-08-26 1976-08-26
US717,905 1976-08-26

Publications (1)

Publication Number Publication Date
CA1092028A true CA1092028A (fr) 1980-12-23

Family

ID=24883964

Family Applications (1)

Application Number Title Priority Date Filing Date
CA284,372A Expired CA1092028A (fr) 1976-08-26 1977-08-09 Composes pharmaceutiques utilises comme bronchodilatateur

Country Status (19)

Country Link
JP (1) JPS5329935A (fr)
AU (1) AU503877B2 (fr)
BE (1) BE858094A (fr)
CA (1) CA1092028A (fr)
DE (1) DE2737735C3 (fr)
DK (1) DK354377A (fr)
FR (1) FR2362629A1 (fr)
GB (1) GB1541991A (fr)
GR (1) GR68687B (fr)
HK (1) HK30981A (fr)
IE (1) IE45768B1 (fr)
IL (1) IL52588A (fr)
LU (1) LU78022A1 (fr)
MY (1) MY8100263A (fr)
NL (1) NL170367C (fr)
NZ (1) NZ184746A (fr)
PT (1) PT66866B (fr)
SE (1) SE7708307L (fr)
ZA (1) ZA774474B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63156327U (fr) * 1987-04-02 1988-10-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899436A (en) * 1959-08-11 chjch
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators

Also Published As

Publication number Publication date
DE2737735B2 (de) 1979-03-08
ZA774474B (en) 1978-06-28
GB1541991A (en) 1979-03-14
NL170367C (nl) 1982-11-01
AU503877B2 (en) 1979-09-27
IE45768B1 (en) 1982-11-17
DE2737735A1 (de) 1978-03-02
LU78022A1 (fr) 1979-05-23
JPS5329935A (en) 1978-03-20
NL7708732A (nl) 1978-02-28
DK354377A (da) 1978-02-27
NZ184746A (en) 1980-02-21
SE7708307L (sv) 1978-02-27
FR2362629A1 (fr) 1978-03-24
HK30981A (en) 1981-07-10
FR2362629B1 (fr) 1980-07-11
GR68687B (fr) 1982-02-01
PT66866A (en) 1977-08-01
MY8100263A (en) 1981-12-31
IL52588A (en) 1980-07-31
IL52588A0 (en) 1977-10-31
PT66866B (en) 1978-12-29
DE2737735C3 (de) 1979-10-25
BE858094A (fr) 1978-02-27
AU2741277A (en) 1979-02-01
IE45768L (en) 1978-02-28

Similar Documents

Publication Publication Date Title
KR960000430B1 (ko) 산화에 안정한 약제 조성물
EP0498069B1 (fr) Nouvelle utilization d'un dérivé de peptide
KR960000431B1 (ko) 안정한된 약제 조성물
JP3617055B2 (ja) ４，５―エポキシモルヒナン誘導体を含有する安定な医薬品組成物
US8450325B2 (en) Methods for reducing the recurrence of cardiac arrhythmia
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
JPWO1999002158A1 (ja) ４，５−エポキシモルヒナン誘導体を含有する安定な医薬品組成物
EP0183527A2 (fr) Médicament absorbable à base de calcitonine
US4717716A (en) Immuno-regulator
EP1885333B1 (fr) Formulation pharmaceutique d apomorphine pour administration buccale
NZ517367A (en) Use of CGRP antagonists and CGRP release inhibitors for combating menopausal hot flashes
EP0220523A3 (fr) Composés de l'acide quinoléinecarboxylique, leur procédés de préparation, composition pharmaceutique et utilisation
EP0315401A3 (fr) Dérivés de xanthine, leur préparation et leurs compositions les contenant
CA1092028A (fr) Composes pharmaceutiques utilises comme bronchodilatateur
FI95348C (fi) Menetelmä suun kautta annettavan nestemäisen koostumuksen valmistamiseksi
CA1316458C (fr) Composition pharmaceutique comprenant des derives d'un piperidinoalcanol
CA1284107C (fr) Prazosin et pirbuterol en association pour la dilatation des bronches
JPH02326B2 (fr)
MXPA97009453A (en) Oral pharmaceutical composition of piperidinoalcanol compounds in the form of soluc
JPS6139287B2 (fr)
US3824315A (en) Method of treatment
JPS632926A (ja) 安定な、注射可能な制吐性組成物
US3821409A (en) Method of treatment
EP0733364A1 (fr) Composition medicamenteuse pour la circulation
CA2018573C (fr) Preparation lyophilisee de la 6-(3-dimethylaminopropionyl) forskoline

Legal Events

Date Code Title Description
MKEX Expiry